MERIT MEDICAL SYSTEMS INC 4
4 · MERIT MEDICAL SYSTEMS INC · Filed May 26, 2017
Insider Transaction Report
Form 4
EDELMAN RICHARD W
Director
Transactions
- Exercise/Conversion
Common Stock, No Par Value
2017-05-25$13.16/sh+13,379$176,068→ 23,563 total - Sale
Common Stock, No Par Value
2017-05-25$34.42/sh−8,563$294,738→ 15,000 total - Sale
Common Stock, No Par Value
2017-05-24$34.50/sh−7,437$256,577→ 10,184 total - Exercise/Conversion
Common Stock, No Par Value
2017-05-24$13.16/sh+11,621$152,932→ 17,621 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2017-05-24−11,621→ 13,379 totalExercise: $13.16From: 2011-06-25Exp: 2017-06-25→ Common Stock (11,621 underlying) - Exercise/Conversion
Non-qualified stock options (right to buy)
2017-05-25−13,379→ 0 totalExercise: $13.16From: 2011-06-25Exp: 2017-06-25→ Common Stock (13,379 underlying)
Holdings
- 25,000
Non-qualified stock options (right to buy)
Exercise: $9.95From: 2014-05-22Exp: 2020-05-22→ Common Stock (25,000 underlying) - 20,000
Non-qualified stock options (right to buy)
Exercise: $13.75From: 2012-08-11Exp: 2018-08-11→ Common Stock (20,000 underlying)
Footnotes (11)
- [F1]The Reporting Person ceased to be a director of the Issuer on March 24, 2017.
- [F10]Became exercisable in equal annual installments of 20% commencing 05/22/2016. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
- [F11]Became exercisable in equal annual installments of 20% commencing 05/26/2017. Installments scheduled for vesting after 5/26/2017 will not be exercisable.
- [F2]The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 7,437 of such shares to pay the exercise price and taxes and issuing the remaining 4,184 shares to the Reporting Person.
- [F3]The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,563 of such shares to pay the exercise price and taxes and issuing the remaining 4,816 shares to the Reporting Person.
- [F4]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to 34.50, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F5]Became exercisable in equal annual installments of 20% commencing 06/25/2011.
- [F6]Became exercisable in equal annual installments of 20% commencing 08/11/2012.
- [F7]Became exercisable in equal annual installments of 20% commencing 05/23/2013.
- [F8]Became exercisable in equal annual installments of 20% commencing 05/22/2014. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
- [F9]Became exercisable in equal annual installments of 20% commencing 06/11/2015. Installments scheduled for vesting after 6/11/2017 will not be exercisable.